21Vianet Group, Inc. to Announce Unaudited Second Quarter 2020 Financial Results
BEIJING, Aug. 07, 2020 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier- and […]
Twin Disc, Inc. Announces Fiscal 2020 Fourth Quarter Financial Results
Fourth quarter gross profit percent improved 60 basis points year-over-yearGenerated $4.3 million of cash from operating activities during the […]
Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020
NEWTOWN, Pa., Aug. 07, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused […]
Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter in Company History – Raises Full Year Guidance
CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fiscal third […]
Orgenesis Second Quarter 2020 Revenue Increases 55% Reflecting Progress of POCare Platform
Provides update on COVID-19 therapeutic programsReports cash and cash equivalents of $97.5 million as of June 30, 2020GERMANTOWN, Md., Aug. […]
Arbutus Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Phase 1a/1b clinical trial for AB-729, a subcutaneously delivered RNAi agent, remains on track with results from additional cohorts expected […]
FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer’s Disease with Priority Review
Priority Review accelerates FDA review time, with a Prescription Drug User Fee Act (PDUFA) target action on March 7, 2021If […]
AnPac Bio Validating Approved COVID-19 Antibody Test
SAN JOSE, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]
Crinetics Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Paltusotine received Orphan Drug Designation for the treatment of acromegalyHalf of the enrolled patients in the ongoing Phase 2 ACROBAT […]
Iovance Biotherapeutics to Present at BTIG Biotechnology Conference 2020
SAN CARLOS, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel […]
